In 1936, CK Friedberg described the existence of lupus disease without cutaneous manifestations.

The pregnancy may stimulate the immune system and may provoke a flare-up of the lupus in the mother.

The peptide, known as P140/LupuzorTM, is well tolerated by patients and leads to regression of the disease.

The peptide, known as P140/LupuzorTM, is well tolerated by patients and leads to regression of the disease.

The sophistication and standardization of detection techniques of antinuclear antibodies will bring genuine diagnostic advances in lupus.

Patients were on a stable SLE treatment regimen consisting of (alone or in combination): corticosteroids, anti-malarials, NSAIDs or other immunosuppressives.

Background medicinal products included corticosteroids (96%; >7.5 mg/day 69%), immunosuppressives (42%), and anti-malarials (67%).

Background medicinal products included corticosteroids (76%; >7.5 mg/day 46%), immunosuppressives (56%), and anti-malarials (63%).

The SLE Responder Index measures improvement in SLE disease activity, without worsening in any organ system, or in the patient’s overall condition.

The SLE Responder Index measures improvement in SLE disease activity, without worsening in any organ system, or in the patient’s overall condition.

Jadassohn, German dermatologist practicing in Berne in Switzerland, in 1904 contributes to the substitution of the term of “Lupus Erythematosus disseminated” by “Lupus Erythematosus Systemic” or better “Lupus disease”.

One such study assessed the effects of green tea on lupus disease activity and studied the improvements in the quality of life of lupus patients.

In 1936, CK Friedberg described the existence of lupus disease without cutaneous manifestations.

Lupus nephritis - kidney inflammation caused by the immune system disease Systemic Lupus Erythematosus (SLE)

an autoimmune disease , such as systemic lupus (lupus glomerulonephritis) or Goodpasture’s syndrome;